Navigation Links
PET-CT Scores High On Precision for Diagnosing Ovarian Cancer Recurrence

Researchers from Massachusetts General Hospital in Boston have established via a study, the high reliability factor of PET-CT for detecting recurrent ovarian cancer// , which is perhaps even more precise than mere CT or PT conducted exclusively.

The researchers analyzed 54 body CT, PET and PET-CT examinations on 53 patients with ovarian cancer who were being studied for recurrence of tumor. The researchers found that PET-CT demonstrated an improved accuracy (49/53, 92%) over CT alone (44/53, 83%) and over PET alone (41/53, 77%).

“We undertook this study because PET-CT is a hot and emerging imaging technique, and its use continues to be evaluated for many indications in the abdomen and pelvis. Also, on CT it is difficult many times to detect ovarian cancer recurrence because of the presence of certain metastatic deposits,” said Sunit Sebastian, MD, who is currently at Emory University School of Medicine and is lead author on the study.

According to the researchers, the results of their study could mean earlier and more definitive detection of recurrent ovarian cancer. “When you combine the advantages of the excellent anatomical depiction that CT gives us and the amount of functional information that PET give us, doctors are better able to monitor cancer patients and manage their treatment accordingly,” said Dr. Sunit Sebastian.

The full results of the study will be presented on May 2, 2006 during the American Roentgen Ray Society Annual Meeting in Vancouver, BC.

Source: Newsise
'"/>




Page: 1

Related medicine news :

1. First PET-CT guided radiotherapy in India was performed by Apollo Hospitals
2. Premier Army Hospital Acquires PET-CT Scanner
3. Milk Chocolate, Cinnamon, And Peppermint Scores Good For Brain
4. Breathing Exercises Scores Over Inhalers
5. Warm Watermelon Scores Over Cold In Nutritive Value
6. Can Giving More Homework Improve Test Scores For Children?
7. PCR emerging as a promising technique for Diagnosing Urinary Tuberculosis
8. Diagnosing Sleep Apnea By Overnight Sleep Testing Method
9. Diagnosing Prostate Cancer is Harder in Obese Individuals
10. MRI Scan Insufficient For Diagnosing Multiple Sclerosis
11. Diagnosing Subarachnoid Hemorrhage

Post Your Comments:
(Date:12/3/2009)...n the life-long focus of his research and now, Pet...mprehensive Cancer Center at Georgetown University...ial-edition of Cancer Epidemiology, Biomarkers & ...actices in tobacco science from researchers the wo...nal of the American Association for Cancer Researc...
(Date:12/2/2009)...SNewswire/ -- The American Association of Poison C...ional Poison Center in Minneapolis, Minnesota as a...tone for the center. The designation by the AAPCC...58 accredited poison centers in the United States....hment. It means we have met the national standards...
(Date:12/2/2009).../ -- Reportlinker.com announces that a new market ..., Renal Disease Treatments: Products and Therapi...nal-Disease-Treatments-Products-and-Therapies.html...and services, providing data for 2008 and estimate...pound annual growth rates (CAGRs) from 2009 to 201...
(Date:12/2/2009).../ -- Reportlinker.com announces that a new market ..., Point of Care Diagnostics ,, http://www.r....html ,, Provides a complete review and analys... ,, Includes market forecasts through 2014 for ...deral regulation of POC testing ,, Analyzes ma...
(Date:12/2/2009).../ -- Reportlinker.com announces that a new market ..., Antibiotic Resistance and Antibiotic Technolog...r.com/p0166825/Antibiotic-Resistance-and-Antibioti...an in-depth review of the global market for antibi..., Offer an analysis of antibiotics resistance from...
Breaking Medicine News(10 mins):Health News:Lombardi's Shields leads special journal focused on tobacco research 2Health News:Hennepin Regional Poison Center Designated as an Accredited Poison Control Center 2Health News:Reportlinker Adds Renal Disease Treatments: Products and Therapies 2Health News:Reportlinker Adds Renal Disease Treatments: Products and Therapies 3Health News:Reportlinker Adds Renal Disease Treatments: Products and Therapies 4Health News:Reportlinker Adds Renal Disease Treatments: Products and Therapies 5Health News:Reportlinker Adds Renal Disease Treatments: Products and Therapies 6Health News:Reportlinker Adds Renal Disease Treatments: Products and Therapies 7Health News:Reportlinker Adds Renal Disease Treatments: Products and Therapies 8Health News:Reportlinker Adds Renal Disease Treatments: Products and Therapies 9Health News:Reportlinker Adds Renal Disease Treatments: Products and Therapies 10Health News:Reportlinker Adds Point of Care Diagnostics 2Health News:Reportlinker Adds Point of Care Diagnostics 3Health News:Reportlinker Adds Point of Care Diagnostics 4Health News:Reportlinker Adds Point of Care Diagnostics 5Health News:Reportlinker Adds Point of Care Diagnostics 6Health News:Reportlinker Adds Point of Care Diagnostics 7Health News:Reportlinker Adds Point of Care Diagnostics 8Health News:Reportlinker Adds Point of Care Diagnostics 9Health News:Reportlinker Adds Point of Care Diagnostics 10Health News:Reportlinker Adds Point of Care Diagnostics 11Health News:Reportlinker Adds Point of Care Diagnostics 12Health News:Reportlinker Adds Antibiotic Resistance and Antibiotic Technologies: Global Markets 2Health News:Reportlinker Adds Antibiotic Resistance and Antibiotic Technologies: Global Markets 3Health News:Reportlinker Adds Antibiotic Resistance and Antibiotic Technologies: Global Markets 4Health News:Reportlinker Adds Antibiotic Resistance and Antibiotic Technologies: Global Markets 5Health News:Reportlinker Adds Antibiotic Resistance and Antibiotic Technologies: Global Markets 6Health News:Reportlinker Adds Antibiotic Resistance and Antibiotic Technologies: Global Markets 7Health News:Reportlinker Adds Antibiotic Resistance and Antibiotic Technologies: Global Markets 8Health News:Reportlinker Adds Antibiotic Resistance and Antibiotic Technologies: Global Markets 9
...t receiving the support they need to stop smoking,...ths from cardiovascular and respiratory illnesses....ffith Universitys School of Medicine, health servi...ss disorder. , He said smoking rates in people w...
...tCall/ - AlphaRx (OTC BB:ALRX -,News), an emerging...rug,delivery technology to develop novel formulati...ical development of Indaflex(TM), its topical NSAI... Cypress acquired Proprius Pharmaceuticals, Inc.,(...
... innovative,weight-loss tool is proud to announce ...rday, May 10th, in less than its first year of ope... alternative among consumers,looking for a healthy...nlike other weight-loss programs, portionpals(R) d...
...c.,(Nasdaq: MEDX ) announced today its financial ...cluding a gain of $151.8 million, or $1.19 per sha...enmab A/S stock in February 2008, Medarex,s,net in...or the same period in 2007. In addition to the gai...
...poration,(Nasdaq: MDTH ), a health care provider ...minantly the diagnosis and treatment of cardiovasc...ior Vice-President and,Treasurer and currently Int...ue to oversee and direct Treasury and,other Financ...
...an,Veterinary Medical Association (AVMA) has revis...e to provide veterinarians with additional guidanc...es. The revised policy,approved on April 12, 2008,...ation by practitioners when they work,with produce...
Other Medicine News:Health News:Quit smoking message not getting air time in mental health care 2Health News:AlphaRx's Indaflex(TM) Continues its Clinical Development 2Health News:Diet Industry Newcomer Hits the 1 Million Unit Mark 2Health News:Medarex Announces 2008 First Quarter Financial Results 2Health News:Medarex Announces 2008 First Quarter Financial Results 3Health News:Medarex Announces 2008 First Quarter Financial Results 4Health News:Medarex Announces 2008 First Quarter Financial Results 5Health News:Medarex Announces 2008 First Quarter Financial Results 6Health News:Medarex Announces 2008 First Quarter Financial Results 7Health News:Medarex Announces 2008 First Quarter Financial Results 8Health News:MedCath Names Parker to New Finance Post 2Health News:Revised AVMA Policy on Castrating and Dehorning Cattle Provides Additional Guidance for Managing Pain 2
(Date:12/3/2009)...Newswire/ -- Upsher-Smith Laboratories, Inc. today...r central nervous system (CNS) diseases with USL25...eloped program for the management of epilepsy. USL...tary formulation technology and will enter a phase...ve treatment of epilepsy patients with partial ons...
(Date:12/3/2009)...-FirstCall/ -- VirtualScopics, Inc. (Nasdaq: VSC...r clinical trials, announced today that its patent...nd Visualization" recently received issuance in Ja...ology and Product Development, Dr. Jonathan Riek, ...the uniqueness of VirtualScopics, science by joini...
(Date:12/3/2009)...lands, December 3 arGEN-X BV, a,bi...nd development of human,antibodies using its propr...ed the successful second closing of its Series A e...ional EUR 3.0 million (~USD 4.5 million),from two ...ivate Equity and,VIB (the prestigious Flemish rese...
Breaking Medicine Technology:Upsher-Smith Announces Milestone in Development of CNS Strategy 2VirtualScopics Receives Issuance in Japan of Prominent Patent 2VirtualScopics Receives Issuance in Japan of Prominent Patent 3arGEN-X Concludes EUR 12.5 Million Series A Financing Round 2arGEN-X Concludes EUR 12.5 Million Series A Financing Round 3arGEN-X Concludes EUR 12.5 Million Series A Financing Round 4Stretching Test May Reveal Arterial Stiffness 59206 1Stretching Test May Reveal Arterial Stiffness 59206 2Smart For Life 28TM 29 Makes Debut on BJs com 59203 1Smart For Life 28TM 29 Makes Debut on BJs com 59203 2Smart For Life 28TM 29 Makes Debut on BJs com 59203 3Genomic Health Announces Data Confirming Manual Microdissection of Biopsy Cavities Is Essential for Accurate Recurrence Risk Assessment in Early Stage 59200 1Genomic Health Announces Data Confirming Manual Microdissection of Biopsy Cavities Is Essential for Accurate Recurrence Risk Assessment in Early Stage 59200 2Genomic Health Announces Data Confirming Manual Microdissection of Biopsy Cavities Is Essential for Accurate Recurrence Risk Assessment in Early Stage 59200 3Genomic Health Announces Data Confirming Manual Microdissection of Biopsy Cavities Is Essential for Accurate Recurrence Risk Assessment in Early Stage 59200 4Genomic Health Announces Data Confirming Manual Microdissection of Biopsy Cavities Is Essential for Accurate Recurrence Risk Assessment in Early Stage 59200 5
...ril 9, 2008 /PRNewswire-FirstCall/ - Echo,Therapeu...sitive results,from its human feasibility study of...ration, needle-free, non-invasive skin permeation ...ransdermal continuous glucose monitoring,(tCGM) sy...ital critical,care markets. Prelude incorporates E...
...ion continuance needed to reduce cardiovascular,ri...o,receive microwave therapy for enlarged prostates...hat could raise their risk of a heart attack or,st... recently in Mayo,Clinic Proceedings., The Mayo C...ceived,transurethral microwave therapy at four med...
Other Medicine Technology:Echo Therapeutics Announces Positive Results with the Prelude(TM) SkinPrep System, the Next-Generation Skin Permeation Medium for its Symphony(TM) Transdermal Continuous Glucose Monitoring System 2Echo Therapeutics Announces Positive Results with the Prelude(TM) SkinPrep System, the Next-Generation Skin Permeation Medium for its Symphony(TM) Transdermal Continuous Glucose Monitoring System 3Echo Therapeutics Announces Positive Results with the Prelude(TM) SkinPrep System, the Next-Generation Skin Permeation Medium for its Symphony(TM) Transdermal Continuous Glucose Monitoring System 4Echo Therapeutics Announces Positive Results with the Prelude(TM) SkinPrep System, the Next-Generation Skin Permeation Medium for its Symphony(TM) Transdermal Continuous Glucose Monitoring System 5Microwave Treatments for Enlarged Prostate Cause Blood Pressure Surges 2Microwave Treatments for Enlarged Prostate Cause Blood Pressure Surges 3
SHERIDAN SOFT-TIP® 6Fr Intubating Stylet
SHERIDAN SHER-I-SLIP® 10Fr Intubating Stylet
Satin-Slip® 10FR Intubating Stylet
SunGlide Stylette Endotracheal Tube Guide - Child
Medicine Products: